Clear Nasal Spray Bottles: Metered-Dose Atomizer Calibration & Intranasal SOP

Systemic administration of peptide therapeutics targeting the central nervous system (CNS) is severely restricted by enzymatic degradation in the gastrointestinal tract and inability to cross the tight capillary junctions of the blood-brain barrier (BBB).

Intranasal atomization delivers aerosolized peptide droplets onto the olfactory mucosa located in the superior nasal vault. Peptides bypass the systemic circulation via non-invasive perineural pathways along the olfactory nerve (cranial nerve I) and ophthalmic/maxillary branches of the trigeminal nerve (cranial nerve V), achieving therapeutic CNS concentrations in cerebrospinal fluid (CSF) within 15–30 minutes.

Clear borosilicate glass atomizer bottles allow real-time visual inspection of solution volume, color, and clarity, ensuring peptide stability throughout long-term administration protocols.

The mechanical atomizer features a stainless steel spring-loaded pump mechanism with an internal pre-compression chamber. Liquid is only discharged when pressure exceeds a calibrated threshold, ensuring high-velocity discharge that breaks the liquid stream into a fine mist rather than large liquid drops.

Conforming to FDA guidance for nasal spray drug products, the actuator generates a standardized plume geometry with an ovality ratio close to 1.0 and a spray cone angle between 30° and 60° at a distance of 3 cm.

Droplet size analysis by laser diffraction confirms that >90% of droplets fall between 20 μm and 120 μm. Droplets <10 μm are avoided to prevent pulmonary inhalation into the lungs, while droplets >150 μm are minimized to prevent anterior nasal dripping.

The atomizer is factory calibrated to deliver exactly 0.10 mL (100 μL) per full mechanical depression.

Stoichiometric Calculation for Semax 10mg: When a 10mg lyophilized vial is reconstituted into a 5.0 mL nasal spray bottle with bacteriostatic water, the resulting concentration is: 10 mg / 5.0 mL = 2.0 mg/mL = 2000 mcg/mL.

Dose Per Spray: 2000 mcg/mL × 0.10 mL/spray = 200 mcg per actuation. A standard 200 mcg dose is delivered with 1 spray; a 400 mcg dose is delivered with 2 sprays (1 spray per nostril). A 5.0 mL fill yields exactly 50 metered actuations.

Step 1: Sanitize exterior surfaces of the glass bottle, atomizer pump, and peptide vial with 70% IPA.

Step 2: Reconstitute the lyophilized peptide cake with 2.0 mL of bacteriostatic water or saline in its original vial, swirling gently until completely dissolved.

Step 3: Using a sterile 5.0 mL syringe with a 21G needle, draw an additional 3.0 mL of bacteriostatic water, inject it into the peptide vial, and mix gently by inversion (total volume = 5.0 mL).

Step 4: Unscrew the atomizer cap from the clean nasal spray bottle. Draw the entire 5.0 mL reconstituted peptide solution into the syringe and smoothly inject it into the open glass bottle.

Step 5: Firmly screw the atomizer pump assembly onto the bottle neck until the silicone gasket is compressed. Snap the protective transparent overcap in place.

Initial Priming: Prior to first analytical use, remove the overcap, point the nozzle away from faces in a fume hood, and depress the pump firmly 3 to 5 times until a uniform, atomized plume is generated. This fills the internal dip-tube and chamber.

Storage: Store the assembled bottle in a vertical upright position at 2°C–8°C in a laboratory refrigerator. Cold-chain storage maintains neuropeptide stability for 30–45 days.

Nozzle Hygiene: After each dispensing event, wipe the exterior of the nozzle orifice with a sterile alcohol swab and replace the protective dust cap to prevent bacterial colonization and nozzle clogging from salt crystallization.